Obstetrics, gynecology and reproductive medicine guidelines

Breast diseases

PubMed Free Full Text

Breast cancer treatment: aromatase inhibitors

Australia

• National Breast and Ovarian Cancer Centre
  • Aromatase inhibitors adjuvant endocrine therapy post-menopausal receptor-positive early bc - NBOCC [2009]

Canada

• Cancer Care Ontario
  • The role of aromatase inhibitors in adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer : a clinical practice guideline [2007]
  • The role of Aromatase inhibitors in the treatment of postmenopausal women with metastatic breast cancer [2003]

International

• Cochrane Library
  • Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women

Sweden

• Swedish Council on Technology Assessment in Health Care
  • Aromatase Inhibitors in Breast Cancer [2005]

United Kingdom

• Bandolier
  • Aromatase inhibitors in advanced breast cancer [2006]

• Health Technology Assessment
  • Hormonal therapies for early breast cancer: systematic review and economic evaluation [2007]

• National Institute for Health and Clinical Excellence
  • Breast cancer (early) - hormonal treatments [2006]

• NHS Quality Improvement Scotland
  • NICE Technology Appraisal Guidance No 112 Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer [2006]

United States of America

• American Society of Clinical Oncology
  • American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Status Report 2004 [2004]

• National Guideline Clearinghouse
  • The role of aromatase inhibitors in adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: a clinical practice. Program in Evidence-based Care [2008]
  • American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor–positive breast cancer: status report 2004 [2004]

Articles in journals

• Annals of Oncology
  • Latest developments in local treatment: radiotherapy for early breast cancer [2005]

• Breast Cancer Research
  • Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions [2005]

• CA - A Cancer Journal for Clinicians
  • Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer [2005]

• Clinical Cancer Research
  • Aromatase Inhibition: Translation into a Successful Therapeutic Approach [2005]

• Endocrine Journal
  • Aromatase in human breast carcinoma as a key regulator of intratumoral sex steroid concentrations [2008]

• Endocrine Reviews
  • Aromatase Inhibitors in the Treatment of Breast Cancer [2005]

• Endocrine-Related Cancer
  • Menopausal symptoms and adjuvant therapy-associated adverse events [2008]
  • Aromatase inhibitors for breast cancer: different structures, same effects? [2008]
  • Novel concepts for the chemoprevention of breast cancer through aromatase inhibition [2006]

• Journal of Postgraduate Medicine
  • Exemestane: A milestone against breast cancer [2007]

• Medical Journal of Australia
  • The aromatase inhibitors in early breast cancer: who, when, and why? [2005]

{Related topics}

• Guidelines
  • Breast cancer treatment